"use strict";(self.webpackChunkBenStockTracker=self.webpackChunkBenStockTracker||[]).push([[5676],{5676:e=>{e.exports=JSON.parse('{"a0089725-5b83-3c31-a965-0625198594ac":{"uuid":"a0089725-5b83-3c31-a965-0625198594ac","title":"Pandemic is still a public health emergency, warns WHO, urging greater surveillance including testing and sequencing","publisher":"MarketWatch","link":"https://finance.yahoo.com/m/a0089725-5b83-3c31-a965-0625198594ac/pandemic-is-still-a-public.html","providerPublishTime":1657724640,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/DMIvAUfUzJuJpxlgvRD_bg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/KTL3tiPIj5va6hJ4ogZD6A--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketwatch.com/d27d3f59663300334d75ec92ae043bd8","width":1280,"height":640,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/tNHW.CHoEorvRsz_vow05A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/KTL3tiPIj5va6hJ4ogZD6A--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketwatch.com/d27d3f59663300334d75ec92ae043bd8","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD","HGEN"]},"a1a382d1-d1af-3ace-98ec-2f2eee40084c":{"uuid":"a1a382d1-d1af-3ace-98ec-2f2eee40084c","title":"Humanigen\'s stock tumbles 67% after sharing new clinical data for its COVID-19 treatment","publisher":"MarketWatch","link":"https://finance.yahoo.com/m/a1a382d1-d1af-3ace-98ec-2f2eee40084c/humanigen%27s-stock-tumbles-67%25.html","providerPublishTime":1657714172,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/0xJmWLb8ZDw3vmCOCZi_VA--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/S8SCotpO9m2XQyQUIGU5dw--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketwatch.com/96d076434b2a015a3010bd2787b8c856","width":1200,"height":630,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/mMzbd204HqZneSMjGpoHGw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/S8SCotpO9m2XQyQUIGU5dw--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketwatch.com/96d076434b2a015a3010bd2787b8c856","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["^GSPC","HGEN","GILD"]},"16d002ea-84f2-3ce8-b1e7-5d879f367902":{"uuid":"16d002ea-84f2-3ce8-b1e7-5d879f367902","title":"Gilead Sciences (GILD) Stock Moves -0.51%: What You Should Know","publisher":"Zacks","link":"https://finance.yahoo.com/news/gilead-sciences-gild-stock-moves-215009664.html","providerPublishTime":1657662609,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/icWwTnXD.RDbbaiJecovTw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/wXNaNKXxuWlbebD.cUCv9g--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653","width":900,"height":600,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/9hmYK3wZFQeDq1Iw4TW61Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/wXNaNKXxuWlbebD.cUCv9g--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD","^GSPC"]},"650c5287-960e-331c-b7b8-c63d2e0174c6":{"uuid":"650c5287-960e-331c-b7b8-c63d2e0174c6","title":"Gilead Sciences to Release Second Quarter 2022 Financial Results on Tuesday, August 2, 2022","publisher":"Business Wire","link":"https://finance.yahoo.com/news/gilead-sciences-release-second-quarter-200500647.html","providerPublishTime":1657656300,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/J6C9EQxPku8N1t1suiOfUg--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/anvIbOqbH6BnMGws0nD_eg--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5730c11a6d15b557b7467df4cfc4ac3b","width":480,"height":160,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/1ntkEZSFidywXLSgHE7PRg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/anvIbOqbH6BnMGws0nD_eg--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5730c11a6d15b557b7467df4cfc4ac3b","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"85ebd338-f7df-358a-81ea-4ecc04b885eb":{"uuid":"85ebd338-f7df-358a-81ea-4ecc04b885eb","title":"Gilead Sciences Appoints Deborah Telman as Executive Vice President, Corporate Affairs and General Counsel","publisher":"Business Wire","link":"https://finance.yahoo.com/news/gilead-sciences-appoints-deborah-telman-123000568.html","providerPublishTime":1657629000,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/YAB9saXEObbt9GAamsyUbQ--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/.yAe_D1aLK.zu.CePlm7IA--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b69c8895941b2ac15232d2af97f8708b","width":480,"height":160,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/fGmf6XcIeYm_FzsEH97emw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/.yAe_D1aLK.zu.CePlm7IA--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b69c8895941b2ac15232d2af97f8708b","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"ad7eb25d-6451-35a5-a95f-1f4007827431":{"uuid":"ad7eb25d-6451-35a5-a95f-1f4007827431","title":"Why NuCana Shares Are Rising Today?","publisher":"Benzinga","link":"https://finance.yahoo.com/news/why-nucana-shares-rising-today-173629597.html","providerPublishTime":1657560989,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/KenCvcBPt4obMpwxNVNz6g--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/PXYrIbQKISoCBIpnqLhu0g--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/948f38dd0264bd69bed94441c380a9c2","width":600,"height":400,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/xFBivnn7oIjP9edVq8JkpQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/PXYrIbQKISoCBIpnqLhu0g--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/948f38dd0264bd69bed94441c380a9c2","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["NCNA","GILD"]},"e34dd628-adf0-3434-bdfd-c24cc017d019":{"uuid":"e34dd628-adf0-3434-bdfd-c24cc017d019","title":"Investing in Gilead Sciences (NASDAQ:GILD) five years ago would have delivered you a 7.5% gain","publisher":"Simply Wall St.","link":"https://finance.yahoo.com/news/investing-gilead-sciences-nasdaq-gild-140215136.html","providerPublishTime":1657461735,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/P2Up_Pi6bmX7LFgZiQoypA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/toOHA4B9c_p415zczXd3bQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/81245609dd3c4b1e638094086514d4fb","width":1194,"height":432,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/IxJGj18DG7tjbB8zwXg3jQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/toOHA4B9c_p415zczXd3bQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/81245609dd3c4b1e638094086514d4fb","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"780aefec-85a8-3db8-bfc9-9983c6b5a6c1":{"uuid":"780aefec-85a8-3db8-bfc9-9983c6b5a6c1","title":"Gilead Sciences Features Cristina Herrera of Translatinx Network","publisher":"News Direct","link":"https://finance.yahoo.com/news/gilead-sciences-features-cristina-herrera-124520476.html","providerPublishTime":1657284320,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/207X16ceMqwFzUoqP6bp.g--~B/aD0zNjY7dz02NTA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/hIXBgXLXzr_j8TiQ90e7DA--~B/aD0zNjY7dz02NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/news_direct/e45905aa429d835568691a3edd9f4cc4","width":650,"height":366,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/KQpZNtpBvtfONHuM_pai8A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/hIXBgXLXzr_j8TiQ90e7DA--~B/aD0zNjY7dz02NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/news_direct/e45905aa429d835568691a3edd9f4cc4","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]}}')}}]);